Ticker Symbol: ICOTF

Satellos Bioscience Inc

Exchange: US OTC Country: CA Currency: USD Asset Type: Common Stock CIK:0001421642

Company Profile

iCo Therapeutics, Inc. is a canadian biotechnology company. It engages in the business of identification, development and commercialization of drug candidates to treat ocular and infectious diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, CA.

Sector: Health Technology

Industry: Pharmaceuticals: Other

Standard Industrial Classification Code (SIC code): 2834

Address: 777 Hornby Street

Website: http://www.icotherapeutics.com

CEO: Bill W. Jarosz

Tags:

Pharmaceuticals: Other
Health Technology

Pricing

Last Updated: December 9, 2021 04:00 PM EST

Previous Close: $0.93

Change: -$0.01 ( -1.29%)

Days Range: $0.93 - $0.93

Beta: -

52wk. High: $1.82

52wk. Low: $0.02

Ytd. Change 1847.48%

50 Day Moving Average: $1.05

200 Day Moving Average: $1.15

Shares Outstanding: 32997613

Valuation

Market Cap: 3.1B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A